Vaccine against HIV/AIDS

In collaboration with IrsiCaixa, the Institut de Recerca de la Sida [AIDS Research Institute] led by Doctor Bonaventura Clotet, advances have been made in research for a therapeutic vaccine to treat HIV/AIDS and reduce its related adverse effects. This initiative has also contributed to research into the influences of the microbiomes in the vaccine.

The study of the immune response in individuals with a high risk of being affected by AIDS assists in the development of strategies to prevent infection. In this regard, support has been given to studies to develop therapeutic vaccines for people who are HIV positive, while work is also being done in monoclonal antibodies that neutralise the action of the virus in the body, heightening the activity of natural killer (NK) cells destined to destroy other cells that have already been infected.

The Glòria Soler Foundation is part of the entities who supported the therapeutic vaccine HTI, at an important moment in development, and participates through IrsiCaixa in the SPIN OFF, Aelix Therapeutics S.L., created in 2016. In recognition, the foundation flaunts through IrsiCaixa a co-ownership percentage of 7,96%.

The company focuses on the discovery and development of immunotherapies against HIV infection. A first round of funding (11.5 million euros) was closed in January 2016. A phase II proof-of-concept clinical trial using the HTI immunogen as a therapeutic vaccine in people with HIV infection is foreseen to be completed by 2020.

World AIDS Day — 1 December

The Glòria Soler Foundation has given its support each 1 December, World AIDS Day, to the AIDS awareness campaign, illuminating the façade of its headquarters in red light.

Through its alliance with the Foundation for the Fight against AIDS, its collaboration in AIDS research is linked to its activity in social sensibility and awareness.

MORTALES+ Community, Art and HIV/AIDS

Blue Soler Therapeutic SUP. Sport and Health

Suñol Soler Collection

Josep Carreras Foundation

Gilead Sciences acquires investigational assets for the HIV vaccine designed at IrsiCaixa and driven by AELIX Therapeutics

Parc Sanitari de Sant Joan de Déu inaugurates the immersive experience ‘Mental State’ based on the works of artist Zush/Evru

Green light for CAR-T ARI0002h developed by Hospital Clínic-IDIBAPS for patients with multiple myeloma

The Glòria Soler Foundation presents ‘Peu i vernís’ by Antoni Tàpies at Clínic Barcelona/IDIBAPS as part of the Tàpies Year

Blue Soler leads first international project to demonstrate the therapeutic benefits of Stand Up Paddle (SUP)

MORTALES+ Community, Art and HIV/AIDS

Blue Soler Therapeutic SUP. Sport and Health